Pharmacy “Medical Mall” Faces Hardship Due to Dispensing Fee Revision, Profitability Decline Expected to Accelerate M&A – Nikkei

The impact of the current dispensing fee revision on "Medical Mall Pharmacies" suggests a shift in the revenue structure of the entire dispensing pharmacy industry and a consequent revitalization of the M&A market.Particularly within medical malls where multiple medical institutions are concentrated, individual pharmacies are highly susceptible to direct impacts from the revision in prescription volume and associated dispensing fees, making profitability decline a critical issue.

From the perspective of medical M&A and business succession, this situation can accelerate consideration of third-party succession, especially for independent dispensing pharmacies and small pharmacies with aging owners.As business models that previously promised stable profits face increased uncertainty due to regulatory changes, M&A becomes a viable option for pharmacy owners grappling with the issue of a lack of successors. This path offers not only the assurance of acquisition value but also the benefits of contributing to regional healthcare and maintaining employee employment, paving the way for a transition to a new management structure.

Medical institution managers and pharmacy owners facing succession issues should recognize that this revision presents an opportune moment to re-analyze their company's revenue structure and concretely consider business succession options.Rather than simply opting for "closure," collaborating with experts and promptly exploring business succession schemes, including M&A, can enable continued business operations under more favorable terms and sustained contribution to the local community.